Doxorubin
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
3042 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 108 | 431 | 202 | 18 | 84 | 776 |
| Lymphoma | D008223 | — | C85.9 | 99 | 318 | 119 | 15 | 35 | 524 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 56 | 167 | 54 | 3 | 11 | 252 |
| Sarcoma | D012509 | — | — | 70 | 131 | 48 | 5 | 23 | 247 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 76 | 112 | 72 | 1 | 16 | 243 |
| Neoplasms | D009369 | — | C80 | 111 | 77 | 15 | 1 | 8 | 182 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 45 | 102 | 40 | 6 | 10 | 177 |
| B-cell lymphoma | D016393 | — | — | 52 | 99 | 26 | 4 | 7 | 155 |
| Carcinoma | D002277 | — | C80.0 | 34 | 73 | 33 | 5 | 26 | 154 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 25 | 60 | 40 | 8 | 34 | 148 |
Show 38 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Triple negative breast neoplasms | D064726 | — | — | 26 | 99 | 20 | — | 9 | 141 |
| Fallopian tube neoplasms | D005185 | — | — | 33 | 35 | 28 | — | 1 | 83 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 11 | 33 | 11 | — | 9 | 58 |
| Recurrence | D012008 | — | — | 20 | 31 | 9 | — | 6 | 57 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 11 | 22 | 16 | — | 3 | 52 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 18 | 27 | 7 | — | 4 | 49 |
| Osteosarcoma | D012516 | — | — | 13 | 23 | 11 | — | 8 | 48 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | 7 | 20 | 20 | — | — | 45 |
| Adenocarcinoma | D000230 | — | — | 9 | 25 | 9 | — | 3 | 41 |
| Peritoneal neoplasms | D010534 | — | — | 12 | 16 | 8 | — | 6 | 38 |
Show 141 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Invasive hydatidiform mole | D002820 | — | D39.2 | 2 | 12 | — | — | — | 14 |
| Non-small-cell lung carcinoma | D002289 | — | — | 5 | 11 | — | — | — | 13 |
| Plasmablastic lymphoma | D000069293 | — | C83.3 | 7 | 6 | — | — | — | 11 |
| Glioblastoma | D005909 | EFO_0000515 | — | 4 | 7 | — | — | — | 10 |
| Cholangiocarcinoma | D018281 | — | C22.1 | 4 | 6 | — | — | 2 | 10 |
| Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | 4 | 6 | — | — | — | 9 |
| Syndrome | D013577 | — | — | 3 | 6 | — | — | — | 9 |
| Aids-related lymphoma | D016483 | EFO_1001365 | — | 4 | 6 | — | — | — | 9 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 4 | 4 | — | — | 4 | 9 |
| Urologic neoplasms | D014571 | — | C64-C68 | 4 | 6 | — | — | — | 8 |
Show 146 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | — | — | — | 4 | 5 |
| Myelodysplastic-myeloproliferative diseases | D054437 | — | — | 4 | — | — | — | — | 4 |
| Appendiceal neoplasms | D001063 | EFO_0003880 | C18.1 | 2 | — | — | — | 2 | 4 |
| Cystadenocarcinoma | D003536 | — | — | 3 | — | — | — | — | 3 |
| Skin neoplasms | D012878 | EFO_0004198 | C44 | 1 | — | — | — | 1 | 2 |
| Sezary syndrome | D012751 | — | C84.1 | 1 | — | — | — | 1 | 2 |
| Pleural effusion | D010996 | — | J90 | 1 | — | — | — | 1 | 2 |
| Pleural neoplasms | D010997 | — | — | 1 | — | — | — | 1 | 2 |
| Brenner tumor | D001948 | — | — | 2 | — | — | — | — | 2 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | — | — | — | — | 1 |
Show 19 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alopecia | D000505 | — | L64 | — | — | — | — | 2 | 2 |
| Pseudomyxoma peritonei | D011553 | EFO_0007456 | — | — | — | — | — | 2 | 2 |
| Human herpesvirus 4 | D004854 | — | — | — | — | — | — | 2 | 2 |
| Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 2 | 2 |
| Taste disorders | D013651 | — | — | — | — | — | — | 1 | 1 |
| Dysgeusia | D004408 | — | R43.2 | — | — | — | — | 1 | 1 |
| Ageusia | D000370 | EFO_1001758 | — | — | — | — | — | 1 | 1 |
| Biliary tract neoplasms | D001661 | — | C24.9 | — | — | — | — | 1 | 1 |
| Fatigue | D005221 | — | R53.83 | — | — | — | — | 1 | 1 |
| Ataxia | D001259 | — | R27.0 | — | — | — | — | 1 | 1 |
Show 40 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
38 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use